William Anderson

William Anderson

Directeur Général chez BAYER AG
59 ans
Health Technology
Commercial Services
Finance

Profil

William N.
Anderson
is currently the Chief Executive Officer at Bayer AG since 2023.
He is also serving as the Director at Chugai Pharmaceutical Co., Ltd. since 2019 and as a Director at Pharmaceutical Research & Manufacturers of America.
Previously, he held the position of Chief Executive Officer & Director at Genentech, Inc. He was also the Chief Executive Officer at Roche Pharmaceuticals, Inc. from 2019 to 2022 and at Roche Pharma (Schweiz) AG from 2019 to 2023.
Prior to that, he worked as the Vice President-Neurology Unit at Biogen, Inc. from 2004 to 2006.
Mr. Anderson completed his graduate degree from Massachusetts Institute of Technology and his undergraduate degree from The University of Texas at Austin.

Postes actifs de William Anderson

SociétésPosteDébut
CHUGAI PHARMACEUTICAL CO., LTD. Directeur/Membre du Conseil 01/03/2019
BAYER AG Directeur Général 01/06/2023
Directeur/Membre du Conseil -

Anciens postes connus de William Anderson

SociétésPosteFin
Directeur Général 01/01/2023
Directeur Général 31/12/2022
BIOGEN INC. Directeur Financier/CFO 01/01/2004
Directeur Général -
Voir l'expérience en détail de William Anderson

Formation de William Anderson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

73

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Consumer Services

Health Technology

Distribution Services

  1. Bourse
  2. Insiders
  3. William Anderson
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇